Laguna Pharmaceuticals, Inc. — Form D
Laguna Pharmaceuticals, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-30. The offering totals $4.7M, of which $4.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-07-30
- Form: D
- Accession: 0001609970-15-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $4.5M
- Remaining: $258K
- Investors: 8
- Date of first sale: 2011-11-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-244746
Issuer
- Name: Laguna Pharmaceuticals, Inc.
- CIK: 0001609970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4225 EXECUTIVE SQUARE, STE. 960, LA JOLLA, CA, 92037
- Phone: (858) 356-7338
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Robert Baltera, Jr. | Director | LA JOLLA, CA |
| Jerel Davis | Director | Alameda, CA |
| Kevin Lalande | Director | Medford, MA |
| James Topper | Director | La Jolla, CA |
| Robert Baltera, Jr. | Executive Officer | LA JOLLA, CA |
| Howard Dittrich | Executive Officer | Kalamazoo, MI |
| Brian Farmer | Executive Officer | San Diego, CA |
| Jim Graham | Director | Austin, TX |
| Arthur Brown | Director | VANCOUVER, A1 |
| Arthur Brown | Executive Officer | VANCOUVER, A1 |
| Rajesh Khosla | Director | Cleveland, OH |
| Rajesh Khosla | Executive Officer | Cleveland, OH |
Other filings by this issuer (2)
More